Search clinical trials for: ibrutinib and Tisagenlecleucel
Total 271377 results
-
AbbVieJanssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company)CompletedCoronaVirus Induced Disease-2019 (COVID-19)United States
-
Janssen-Cilag Farmaceutica Ltda.Approved for marketingB-cell Chronic Lymphocytic LeukemiaBrazil
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Washington University School of MedicinePharmacyclics LLC.Completed
-
H. Lee Moffitt Cancer Center and Research InstitutePharmacyclics LLC.CompletedCarcinoid Tumors | Pancreatic NETUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | Small Lymphocytic LeukemiaUnited States
-
Sunnybrook Health Sciences CentreNovartisUnknownLeukemia, Lymphocytic, Chronic, B-CellCanada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedIbrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell TransplantRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Follicular Lymphoma | Refractory Follicular...United States
-
Dana-Farber Cancer InstitutePharmacyclics LLC.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
X4 PharmaceuticalsCompletedWaldenstrom's MacroglobulinemiaUnited States, Greece
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
University of PennsylvaniaNot yet recruiting
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, Spain, Belgium, Germany, Russian Federation
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Esanex Inc.TerminatedCancerUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
Incyte CorporationCompleted
-
German CLL Study GroupJanssen-Cilag Ltd.CompletedChronic Lymphocytic LeukemiaGermany
-
University of Michigan Rogel Cancer CenterWithdrawnMantle Cell LymphomaUnited States
-
University Hospital, CaenNot yet recruitingAtrial Fibrillation | Hematological MalignancyFrance
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Dana-Farber Cancer InstituteCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedB-cell Lymphoma | Marginal Zone LymphomaUnited States, Belgium, France, Germany, United Kingdom
-
Janssen Research & Development, LLCCompleted
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
Novartis PharmaceuticalsTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Eugene NikitinUnknownAIHA - Warm Autoimmune Hemolytic AnemiaRussian Federation
-
Rabin Medical CenterJanssen, LPRecruitingCentral Nervous System LymphomaIsrael
-
National Cancer Centre, SingaporeSamsung Medical Center; Singapore General HospitalTerminatedLymphoma, B-Cell, Marginal ZoneSingapore
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingLeukemia, Lymphoblastic, ChronicItaly
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Terminated
-
Pharmacyclics LLC.CompletedDiffuse Large Cell B-lymphomaUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruitingChronic Lymphocytic LeukemiaChina